| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 471.740.439 $ | 99,92 | 9.471.944 | ||||||
| Abbott Laboratories | Abbott Laboratories | EC | 002824100 | Long | Börsenkurs (Stufe 1) | 26.775.607 $ | 5,67 | 253.317 | |
| AbbVie Inc. | AbbVie Inc. | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 25.856.356 $ | 5,48 | 103.038 | |
| Amgen Inc. | Amgen Inc. | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 25.173.672 $ | 5,33 | 65.359 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 24.448.869 $ | 5,18 | 95.373 | |
| Merck & Co., Inc. | Merck & Co., Inc. | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 23.873.863 $ | 5,06 | 183.363 | |
| Eli Lilly and Co. | Eli Lilly and Co. | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 23.691.378 $ | 5,02 | 20.622 | |
| Corcept Therapeutics Inc. | Corcept Therapeutics Inc. | EC | 218352102 | Long | Börsenkurs (Stufe 1) | 23.426.715 $ | 4,96 | 204.618 | |
| Gilead Sciences, Inc. | Gilead Sciences, Inc. | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 21.378.138 $ | 4,53 | 164.182 | |
| Pfizer Inc. | Pfizer Inc. | EC | 717081103 | Long | Börsenkurs (Stufe 1) | 21.242.319 $ | 4,50 | 849.353 | |
| Amneal Pharmaceuticals, Inc. | Amneal Pharmaceuticals, Inc. | EC | 03168L105 | Long | Börsenkurs (Stufe 1) | 17.688.784 $ | 3,75 | 965.545 | |
| Liquidia Corp. | Liquidia Corp. | EC | 53635D202 | Long | Börsenkurs (Stufe 1) | 17.283.932 $ | 3,66 | 205.492 | |
| Travere Therapeutics, Inc. | Travere Therapeutics, Inc. | EC | 89422G107 | Long | Börsenkurs (Stufe 1) | 15.586.380 $ | 3,30 | 278.876 | |
| Ligand Pharmaceuticals Inc. | Ligand Pharmaceuticals Inc. | EC | 53220K504 | Long | Börsenkurs (Stufe 1) | 15.092.975 $ | 3,20 | 52.490 | |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 14.840.780 $ | 3,14 | 19.460 | |
| Harmony Biosciences Holdings, Inc. | Harmony Biosciences Holdings, Inc. | EC | 413197104 | Long | Börsenkurs (Stufe 1) | 14.464.188 $ | 3,06 | 410.448 | |
| Bristol-Myers Squibb Co. | Bristol-Myers Squibb Co. | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 13.899.470 $ | 2,94 | 212.823 | |
| Viatris Inc. | Viatris Inc. | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 13.337.399 $ | 2,83 | 759.533 | |
| Jazz Pharmaceuticals PLC | Jazz Pharmaceuticals PLC | EC | G50871105 | Long | Börsenkurs (Stufe 1) | 13.160.604 $ | 2,79 | 52.047 | |
| Biogen Inc. | Biogen Inc. | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 12.974.391 $ | 2,75 | 63.929 | |
| Collegium Pharmaceutical, Inc. | Collegium Pharmaceutical, Inc. | EC | 19459J104 | Long | Börsenkurs (Stufe 1) | 12.939.716 $ | 2,74 | 365.632 | |
| Prestige Consumer Healthcare Inc. | Prestige Consumer Healthcare Inc. | EC | 74112D101 | Long | Börsenkurs (Stufe 1) | 12.915.831 $ | 2,74 | 257.185 | |
| Ocular Therapeutix, Inc. | Ocular Therapeutix, Inc. | EC | 67576A100 | Long | Börsenkurs (Stufe 1) | 12.170.759 $ | 2,58 | 1.489.689 | |
| ANI Pharmaceuticals, Inc. | ANI Pharmaceuticals, Inc. | EC | 00182C103 | Long | Börsenkurs (Stufe 1) | 12.021.659 $ | 2,55 | 151.712 | |
| Tarsus Pharmaceuticals, Inc. | Tarsus Pharmaceuticals, Inc. | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 11.921.947 $ | 2,53 | 201.930 | |
| Perrigo Co. PLC | Perrigo Co. PLC | EC | G97822103 | Long | Börsenkurs (Stufe 1) | 11.561.058 $ | 2,45 | 1.143.527 | |
| Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. | EC | 868459108 | Long | Börsenkurs (Stufe 1) | 11.536.766 $ | 2,44 | 258.498 | |
| Innoviva, Inc. | Innoviva, Inc. | EC | 45781M101 | Long | Börsenkurs (Stufe 1) | 11.418.081 $ | 2,42 | 544.496 | |
| United Therapeutics Corp. | United Therapeutics Corp. | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 11.058.803 $ | 2,34 | 21.361 | |
| OmniAb, Inc. | OmniAb, Inc., Rts., expiring 2027-11-02 | EC | 68218J301 | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 78.046 | |
| Gesamt | 471.740.439 $ | 99,92 | 9.471.944 |